Use of a metaplasticity-based protocol of therapeutic transcranial magnetic stimulation in patients with progressive multiple sclerosis and spasticity: first experience

Background. Spasticity is a disabling syndrome frequently observed in progressive multiple sclerosis. One of the promising approaches to the treatment of spasticity is the use of therapeutic intermittent theta‑burst transcranial magnetic stimulation. In the last time new metaplasticity‑based protoco...

Full description

Bibliographic Details
Main Authors: I. S. Bakulin, A. G. Poydasheva, A. H. Zabirova, D. Yu. Lagoda, A. A. Rimkevichus, M. N. Zakharova, N. A. Suponeva, M. A. Piradov
Format: Article
Language:Russian
Published: ABV-press 2022-09-01
Series:Нервно-мышечные болезни
Subjects:
Online Access:https://nmb.abvpress.ru/jour/article/view/497
_version_ 1797723305775464448
author I. S. Bakulin
A. G. Poydasheva
A. H. Zabirova
D. Yu. Lagoda
A. A. Rimkevichus
M. N. Zakharova
N. A. Suponeva
M. A. Piradov
author_facet I. S. Bakulin
A. G. Poydasheva
A. H. Zabirova
D. Yu. Lagoda
A. A. Rimkevichus
M. N. Zakharova
N. A. Suponeva
M. A. Piradov
author_sort I. S. Bakulin
collection DOAJ
description Background. Spasticity is a disabling syndrome frequently observed in progressive multiple sclerosis. One of the promising approaches to the treatment of spasticity is the use of therapeutic intermittent theta‑burst transcranial magnetic stimulation. In the last time new metaplasticity‑based protocols are being developed in order to increase the effectiveness of this technique. These protocols consist of several stimulation sessions in a day with an interval between sessions. However, there is no experience of use of such protocols in spasticity so far.Aim. To assess the safety and tolerability as well as provide first evidence of anti‑spastic effects of an original meta-plasticity‑based intermittent theta‑burst stimulation protocol in patients with progressive multiple sclerosis and spasticity.Materials and methods. In total, 5 patients with progressive multiple sclerosis and spasticity (2 females and 3 males, 28–53 y. o., disease duration – 11–18 years, EDSS – 6.5–8.5 points) were included into the study. 3 sessions of stimulation separated by an interval of 1 hour were applied daily, where a single session consisted of 3 protocols of theta‑burst stimulation with standard duration. Stimulation target was the area of cortical representation of the leg muscles, stimulation was applied consequently to both sides during 5 days (15 sessions in total). Before and after the treatment course anti‑spastic effect (modified Ashworth scale) as well as spasticity‑related pain, fatigue and clinical global impression were assessed.Results. No serious adverse events were observed during the study. Mild adverse events (sleepiness, pain at the stimulation site) developed in some cases, which did not affect patients’ willing to continue participation in the study. After the stimulation course decrease in spasticity in the legs was registered in 4 of 5 patients (to 12–39 % from the basic level). Decrease of fatigue (4 / 5) and pain severity (3 / 5) was also observed.Conclusion. According to the first experience, the proposed original metaplasticity‑based transcranial magnetic stimulation protocol is safe, well‑tolerable and potentially effective in patients with progressive multiple sclerosis. Therefore the further investigation of the protocol in a randomized controlled study seems justified.
first_indexed 2024-03-12T09:59:57Z
format Article
id doaj.art-070a5023edc34dd088f4abbafdd0a1cf
institution Directory Open Access Journal
issn 2222-8721
2413-0443
language Russian
last_indexed 2024-03-12T09:59:57Z
publishDate 2022-09-01
publisher ABV-press
record_format Article
series Нервно-мышечные болезни
spelling doaj.art-070a5023edc34dd088f4abbafdd0a1cf2023-09-02T11:44:08ZrusABV-pressНервно-мышечные болезни2222-87212413-04432022-09-01123263510.17650/2222-8721-2022-12-3-26-35325Use of a metaplasticity-based protocol of therapeutic transcranial magnetic stimulation in patients with progressive multiple sclerosis and spasticity: first experienceI. S. Bakulin0A. G. Poydasheva1A. H. Zabirova2D. Yu. Lagoda3A. A. Rimkevichus4M. N. Zakharova5N. A. Suponeva6M. A. Piradov7ФГБНУ «Научный центр неврологии»ФГБНУ «Научный центр неврологии»ФГБНУ «Научный центр неврологии»ФГБНУ «Научный центр неврологии»ФГБНУ «Научный центр неврологии»ФГБНУ «Научный центр неврологии»ФГБНУ «Научный центр неврологии»ФГБНУ «Научный центр неврологии»Background. Spasticity is a disabling syndrome frequently observed in progressive multiple sclerosis. One of the promising approaches to the treatment of spasticity is the use of therapeutic intermittent theta‑burst transcranial magnetic stimulation. In the last time new metaplasticity‑based protocols are being developed in order to increase the effectiveness of this technique. These protocols consist of several stimulation sessions in a day with an interval between sessions. However, there is no experience of use of such protocols in spasticity so far.Aim. To assess the safety and tolerability as well as provide first evidence of anti‑spastic effects of an original meta-plasticity‑based intermittent theta‑burst stimulation protocol in patients with progressive multiple sclerosis and spasticity.Materials and methods. In total, 5 patients with progressive multiple sclerosis and spasticity (2 females and 3 males, 28–53 y. o., disease duration – 11–18 years, EDSS – 6.5–8.5 points) were included into the study. 3 sessions of stimulation separated by an interval of 1 hour were applied daily, where a single session consisted of 3 protocols of theta‑burst stimulation with standard duration. Stimulation target was the area of cortical representation of the leg muscles, stimulation was applied consequently to both sides during 5 days (15 sessions in total). Before and after the treatment course anti‑spastic effect (modified Ashworth scale) as well as spasticity‑related pain, fatigue and clinical global impression were assessed.Results. No serious adverse events were observed during the study. Mild adverse events (sleepiness, pain at the stimulation site) developed in some cases, which did not affect patients’ willing to continue participation in the study. After the stimulation course decrease in spasticity in the legs was registered in 4 of 5 patients (to 12–39 % from the basic level). Decrease of fatigue (4 / 5) and pain severity (3 / 5) was also observed.Conclusion. According to the first experience, the proposed original metaplasticity‑based transcranial magnetic stimulation protocol is safe, well‑tolerable and potentially effective in patients with progressive multiple sclerosis. Therefore the further investigation of the protocol in a randomized controlled study seems justified.https://nmb.abvpress.ru/jour/article/view/497спастичностьрассеянный склерозтранскраниальная магнитная стимуляциянейромодуляциянеинвазивная стимуляция мозгаметапластичность
spellingShingle I. S. Bakulin
A. G. Poydasheva
A. H. Zabirova
D. Yu. Lagoda
A. A. Rimkevichus
M. N. Zakharova
N. A. Suponeva
M. A. Piradov
Use of a metaplasticity-based protocol of therapeutic transcranial magnetic stimulation in patients with progressive multiple sclerosis and spasticity: first experience
Нервно-мышечные болезни
спастичность
рассеянный склероз
транскраниальная магнитная стимуляция
нейромодуляция
неинвазивная стимуляция мозга
метапластичность
title Use of a metaplasticity-based protocol of therapeutic transcranial magnetic stimulation in patients with progressive multiple sclerosis and spasticity: first experience
title_full Use of a metaplasticity-based protocol of therapeutic transcranial magnetic stimulation in patients with progressive multiple sclerosis and spasticity: first experience
title_fullStr Use of a metaplasticity-based protocol of therapeutic transcranial magnetic stimulation in patients with progressive multiple sclerosis and spasticity: first experience
title_full_unstemmed Use of a metaplasticity-based protocol of therapeutic transcranial magnetic stimulation in patients with progressive multiple sclerosis and spasticity: first experience
title_short Use of a metaplasticity-based protocol of therapeutic transcranial magnetic stimulation in patients with progressive multiple sclerosis and spasticity: first experience
title_sort use of a metaplasticity based protocol of therapeutic transcranial magnetic stimulation in patients with progressive multiple sclerosis and spasticity first experience
topic спастичность
рассеянный склероз
транскраниальная магнитная стимуляция
нейромодуляция
неинвазивная стимуляция мозга
метапластичность
url https://nmb.abvpress.ru/jour/article/view/497
work_keys_str_mv AT isbakulin useofametaplasticitybasedprotocoloftherapeutictranscranialmagneticstimulationinpatientswithprogressivemultiplesclerosisandspasticityfirstexperience
AT agpoydasheva useofametaplasticitybasedprotocoloftherapeutictranscranialmagneticstimulationinpatientswithprogressivemultiplesclerosisandspasticityfirstexperience
AT ahzabirova useofametaplasticitybasedprotocoloftherapeutictranscranialmagneticstimulationinpatientswithprogressivemultiplesclerosisandspasticityfirstexperience
AT dyulagoda useofametaplasticitybasedprotocoloftherapeutictranscranialmagneticstimulationinpatientswithprogressivemultiplesclerosisandspasticityfirstexperience
AT aarimkevichus useofametaplasticitybasedprotocoloftherapeutictranscranialmagneticstimulationinpatientswithprogressivemultiplesclerosisandspasticityfirstexperience
AT mnzakharova useofametaplasticitybasedprotocoloftherapeutictranscranialmagneticstimulationinpatientswithprogressivemultiplesclerosisandspasticityfirstexperience
AT nasuponeva useofametaplasticitybasedprotocoloftherapeutictranscranialmagneticstimulationinpatientswithprogressivemultiplesclerosisandspasticityfirstexperience
AT mapiradov useofametaplasticitybasedprotocoloftherapeutictranscranialmagneticstimulationinpatientswithprogressivemultiplesclerosisandspasticityfirstexperience